Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by valueplaysonlyon Apr 04, 2013 7:48pm
418 Views
Post# 21213290

thinking about gordie howe

thinking about gordie howe

This  was the highest close for RVX in over two  years.  This stock   has had three monster spikes in the  last 5 years and this is the longest time in between those spikes.    The difference is      5 years ago  PFE  and MRK      and other drug companies   werent the sector favorite.  This   so far is the year of big pharma  and    these trends usullay last  for a few years.  ABT  and  PFE  are in big   break  out mode.  Aquisitions   of small potato companies  like  RVX  cost a penny for these companies  to shill  out now,   but  they  have silver  dollar potential  for many years.

RVX  could  be due for  thr mother of all moster runs.   I remember   one year  I  held company called BIOMIRA.  It went from  3  bucks  to 18 in a month.  With money in the bank   ensuring phase  3  and probably even    federal  money  if it needed a bridge  this  is a no  brainer.  With good results  the  several hundred    billion market cap companies  wil l be all over this.

  The recent  media attention  of both  Gordie Howe  and  Glen  Campbell  will  put  Alzheimer's in the spotlight  and    the  drugs in the pipeline and the current stuff is pretty much useless.  This   has  game  changer  potential    and the research    thus far is worth  a billion  dollars alone in terms of     new direction.  If    RVX  takes this  to Phase 3  this can   be worth  25.   If some one  wants to  buy  it and throw their own   muscle   into the phase 3 its worth  8   or   9 right now.  This  is a " pays  me now or pays me later"  story.

Bullboard Posts